Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition
about
GSK3 regulates mitotic chromosomal alignment through CRMP4Crystal structure of human CRMP-4: correction of intensities for lattice-translocation disorderALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the diseaseThe UNC-6/Netrin receptors UNC-40/DCC and UNC-5 inhibit growth cone filopodial protrusion via UNC-73/Trio, Rac-like GTPases and UNC-33/CRMP.Crmp4 deletion promotes recovery from spinal cord injury by neuroprotection and limited scar formation.A chemical screen identifies novel compounds that overcome glial-mediated inhibition of neuronal regeneration.Collapsin response mediator proteins regulate neuronal development and plasticity by switching their phosphorylation status.Fyn promotes phosphorylation of collapsin response mediator protein 1 at tyrosine 504, a novel, isoform-specific regulatory site.Collapsin response mediator protein 4 regulates growth cone dynamics through the actin and microtubule cytoskeleton.Sevoflurane induces short-term changes in proteins in the cerebral cortices of developing rats.Enhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis.A molecular mechanism for ibuprofen-mediated RhoA inhibition in neuronsRhoA inactivation prevents photoreceptor axon retraction in an in vitro model of acute retinal detachment.Chronic exposure to light reverses the effect of maternal separation on proteins in the prefrontal cortex.What Are the bona fide GSK3 Substrates?Poly(trimethylene carbonate-co-ε-caprolactone) promotes axonal growth.CRMP4 and CRMP2 Interact to Coordinate Cytoskeleton Dynamics, Regulating Growth Cone Development and Axon ElongationRho/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damageCollapsin Response Mediator Protein-1 Regulates Arp2/3-dependent Actin AssemblyStage-specific gene expression is a fundamental characteristic of rat spermatogenic cells and Sertoli cellsThe therapeutic effects of Rho-ROCK inhibitors on CNS disorders.Targeting CRMP-4 by lentivirus-mediated RNA interference inhibits SW480 cell proliferation and colorectal cancer growthDihydropyrimidinase-like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastomaNogo-A represses anatomical and synaptic plasticity in the central nervous system.Neuronal cytoskeleton in synaptic plasticity and regeneration.Postnatal alteration of collapsin response mediator protein 4 mRNA expression in the mouse brain.Function of Nogo-A/Nogo-A receptor in Alzheimer's disease.CRMPs: critical molecules for neurite morphogenesis and neuropsychiatric diseases.In vitro models of axon regeneration.CRMPs Function in Neurons and Glial Cells: Potential Therapeutic Targets for Neurodegenerative Diseases and CNS Injury.Deletion of collapsin response mediator protein 4 results in abnormal layer thickness and elongation of mitral cell apical dendrites in the neonatal olfactory bulb.Extrinsic and intrinsic regulation of axon regeneration at a crossroads.Binocular pattern deprivation interferes with the expression of proteins involved in primary visual cortex maturation in the cat.Collapsin response mediator protein 4 affects the number of tyrosine hydroxylase-immunoreactive neurons in the sexually dimorphic nucleus in female mice.Human CRMP4 mutation and disrupted Crmp4 expression in mice are associated with ASD characteristics and sexual dimorphism.Collapsin response-mediator protein 5 (CRMP5) phosphorylation at threonine 516 regulates neurite outgrowth inhibition.RhoE deficiency alters postnatal subventricular zone development and the number of calbindin-expressing neurons in the olfactory bulb of mouse.CRMP4 suppresses apical dendrite bifurcation of CA1 pyramidal neurons in the mouse hippocampus.Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.CRMP4 Inhibits Bone Formation by Negatively Regulating BMP and RhoA Signaling.
P2860
Q27315343-742B446C-5D9F-44E7-AECB-04430A0252C3Q27684268-89D47873-4BBF-48C1-9115-0A05D2D09F72Q28392297-0A98C341-FD96-4104-9C27-3399F44167E3Q30617477-3ED3760D-666E-4CED-B9DB-D80C884CCBCCQ30619667-30855372-2592-412C-A159-A9C71DBA206DQ33548229-436A9E9D-1542-4949-8115-F92D81D09765Q34255835-C0462FC0-4F60-4459-B7BE-B10DAA7197F9Q34344601-9967271D-F92B-4A41-9E84-30CF4EBEA4C0Q34397025-61BCB3BE-F362-404B-9045-38FBF31357BEQ34491855-2B7C4E80-C494-4573-869E-F07E8538465FQ34519820-F77D8AAC-D06A-4E53-96FE-3AD4D605F8D5Q34615989-5754AA25-50FC-45D5-9EFF-084E74038161Q34646834-F04BFCF3-A322-46D6-910E-133B48C19B1EQ34864441-B6613819-247A-408A-B89C-CB21D8BD677BQ35001234-7669AFEA-C506-4D99-9CF3-A2264714C714Q35106147-0875C26B-E53E-4337-B850-33854E7322D1Q35639541-9151EE96-C153-41CB-B75F-D586475EB524Q35924101-440BDE07-D2DD-4E91-B26C-8F600EC6EB46Q36442357-FA59C5EF-7094-466E-9C34-FBCEB5FA61EBQ36751491-1DCAB11F-B35B-4203-9C26-D9F2E37F4F4FQ36818193-EFB86337-2E2E-49BE-B264-61CB6D46BABAQ37287553-E87E6452-06C6-4DE8-81D7-934EEA803014Q37568951-627A2548-486D-4FD8-8886-C510D743DB3BQ38103436-261587F4-26DE-4311-AFCC-29EBFDFE911FQ38154639-B64DC337-0E22-4B0A-9928-C8CD6B28ECFDQ38323379-69FA1299-F0CD-4A34-81AD-6E69920502F0Q38366946-F6C69C26-91F7-4C0A-8005-2D395D63B87BQ38528533-ADA58A7E-1074-4892-AD8E-856012861DDFQ38716618-34EF289A-A426-433B-8DDA-528D45B7F1E3Q38875531-61E91E43-C070-4B4A-BD84-F421AE527BB5Q40134656-01B8BDDA-74D9-4294-9685-DBC4547405DAQ42428107-1F23B1E9-C35E-4CD0-985C-90CC20FB819CQ42532038-1BEFA01F-B082-4281-88C2-F8B1EA7C9A0BQ44848862-43ED3D01-82A3-4B04-AD5E-372206BA10AFQ47108269-83843880-DF51-4D65-97F9-132D51D2B395Q48650514-5CC68A77-8866-45B3-98D8-6A9DB1ADF4D2Q48667642-98C0412B-5980-401D-A5EE-C64ECA4EAA05Q48718234-02E6ECBB-8CE3-48F6-B027-E3C77FD1341BQ50868527-58B54217-06D3-472A-A978-572599AC03EEQ51235591-9A0287B8-2A34-4774-9B00-941A6329DA0A
P2860
Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition
description
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im Februar 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/02/14)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/02/14)
@nl
наукова стаття, опублікована в лютому 2007
@uk
مقالة علمية (نشرت في 14-2-2007)
@ar
name
Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition
@ast
Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition
@en
Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition
@nl
type
label
Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition
@ast
Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition
@en
Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition
@nl
prefLabel
Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition
@ast
Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition
@en
Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition
@nl
P2093
P3181
P1476
Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition
@en
P2093
Alyson E Fournier
Madeline Pool
Stephan Ong Tone
Yazan Z Alabed
P304
P3181
P356
10.1523/JNEUROSCI.5055-06.2007
P407
P577
2007-02-01T00:00:00Z